Report Highlights
The global market for sleep aids should grow from $81.2 billion in 2020 to $112.7 billion by 2025 with a compound annual growth rate (CAGR) of 6.8% for the period of 2020-2025.
Report Includes
- 25 data tables and 46 additional tables
- A comprehensive analysis of the global markets for sleep aids within the industry and its sub-segments
- Analyses of the global market trends, with data from 2018,2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Detailed insights into factors driving and restraining the growth of the global sleep aids market
- Estimation of the actual market size and revenue forecasts for sleep aids and related technologies, and corresponding market share analysis on the basis of type of product and sleep disorder with major regions and countries involved
- Impact of COVID-19 pandemic on the growth of global sleep aids market vs. the overall global economy
- Country specific data and analysis for the U.S., Canada, France, Germany, U.K., Spain, Italy, Japan, China, India, Australia, South Korea, and other emerging economies
- Competitive landscape featuring major market participants of the global sleep aids industry, and a Porter’s Five Forces analysis considering both the micro and macro environmental factors prevailing in the market
- Descriptive company profiles of the leading sleep aids industry players, including Apnea Sciences Corp., Boehringer Ingelheim International Gmbh, Cleveland Medical Devices Inc., Fisher & Paykel Healthcare Corp. Ltd., Pfizer Inc., and Resmed
Report Scope
This report offers a detailed picture of the sleep aids market.
This report highlights the current and future market potential for sleep aids and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as key market players.
This report details market shares for sleep aids based on product, sleep disorder and geography. Based on product, the market is segmented into mattresses and pillows, sleep apnea devices, medications, sleep laboratories, and home sleep tests. Based on sleep disorder, the market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS) and others.
By geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2019 as the base year, with forecasts for 2020 through 2025. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- The Global Market for Carotenoids (FOD025H)
- AI in Healthcare Regional Analysis Market: Middle East and North Africa (IFT314A)
- Polyester Resin: Global Markets (CHM156B)
- Global Markets and Technologies for Bioplastics (PLS050G)
- 2024 Manufacturing Research Review (MFG071D)
Report Highlights
The global market for sleep aids and technologies is expected to reach $84.9 billion by 2021 from $66.3 billion in 2016, rising at a compound annual growth rate (CAGR) of 5.1% from 2016 through 2021.
Report Highlights
The global market for sleep aids totaled $54.9 billion in 2013. This market is estimated to grow at a compound annual growth rate (CAGR) of 5.6% to reach $58.5 billion in 2014 and $76.7 billion by 2019.
Report Highlights
-
The worldwide sleep aids markets reached revenues of $25 billion in 2009. Revenues are anticipated to reach $33.2 billion in 2014, growing at a compound annual growth rate (CAGR) of 5.8% over the forecast period of 2009 to 2014.
-
The largest market in terms of annual revenues is the mattresses and pillows segment, but it is currently the slowest growing of all the markets. This segment was worth $10.6 billion in 2009 and is expected to reach $12.5 billion by 2015, a compound annual growth rate (CAGR) of 3.3%.
-
The second-largest market is sleep laboratories, with revenues of $6.7 billion in 2009. This segment is expected to grow at a compound annual growth rate (CAGR) of 6.5% to reach $9.2 billion in 2014.
Related Reports
Anesthesia and Respiratory Devices: Global Markets
The global anesthesia and respiratory devices market should reach $36.2 billion by 2022 and more than $51 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Patient Monitoring Devices: Global Markets
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
Recent Reports
Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa
This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.
Intravenous (IV) Therapy and Vein Access: Global Markets
The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
Global Colorectal Cancer Screening and Diagnostics Market
The global market for colorectal cancer screening and diagnostic testing services is estimated to increase from $40.0 billion in 2024 to reach $46.1 billion by 2029, at a compound annual growth rate (CAGR) of 2.9% from 2024 through 2029.
Medical Imaging: A BCC Research Outlook
The global market for medical imaging is expected to grow from $63.4 billion in 2024 and is projected to reach $82.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.
In Vitro Diagnostics: Technologies and Global Markets
The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
Top Trending Reports
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
Cell-Based Assays: Technologies and Global Markets
The global market for cell-based assays is estimated to increase from $35.3 billion in 2024 to reach $56.3 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Markets for Chemicals for Cosmetics & Toiletries
The global market for chemicals in cosmetics and toiletries is expected to grow from $27.7 billion in 2024 to $35.0 billion by 2029, at a compound annual growth rate (CAGR) of 4.8% from 2024 through 2029.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More